ALLO (STOCKS)
Allogene Therapeutics, Inc. Common Stock
$2.010000
-0.060000 (-2.90%)
Prev close: $2.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Zachary Roberts
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $766.89M
- Employees
- 361
- P/E (TTM)
- -2.69
- P/B (TTM)
- 1.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.13 | $-0.17 | +0.0445 | +25.50% |
|
Mar 2026 (Q1)
|
$-0.18 | $-0.19 | +0.0142 | +7.31% |
|
Dec 2025 (Q4)
|
$-0.17 | $-0.22 | +0.0507 | +22.97% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.23 | +0.0377 | +16.56% |